SLC6A6 and cancer: These findings suggest that tumor-induced SLC6A6-mediated taurine deficiency promotes immune evasion while taurine supplementation revitalizes exhausted CD8+ T cells and enhances the effectiveness of cancer therapies, aligning with our results.